https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-29 / Future Sci OA 2019 Oct;5(10):FSO435
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-29 / Future Sci OA 2019 Oct;5(10):FSO4352019-10-29 00:00:002019-10-29 00:00:00Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN in combination with chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-28 / Mol. Hum. Reprod. 2019 10;25(10):601-613
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-28 / Mol. Hum. Reprod. 2019 10;25(10):601-6132019-10-28 00:00:002019-10-28 00:00:00Vitamin C protects carboplatin-exposed oocytes from meiotic failure
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-24 / Immunology 2020 01;159(1):75-87
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-24 / Immunology 2020 01;159(1):75-872019-10-24 00:00:002019-10-24 00:00:00Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-23 / Adv Sci (Weinh) 2019 Dec;6(24):1901779
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-23 / Adv Sci (Weinh) 2019 Dec;6(24):19017792019-10-23 00:00:002019-10-23 00:00:00Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-17 / Pathol. Res. Pract. 2019 Dec;215(12):152691
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-17 / Pathol. Res. Pract. 2019 Dec;215(12):1526912019-10-17 00:00:002019-10-17 00:00:00Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-11 / Biomedicines 2019 Oct;7(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-11 / Biomedicines 2019 Oct;7(4)2019-10-11 00:00:002021-05-19 12:40:37Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-11 / Front Pharmacol 2019;10:1152
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-11 / Front Pharmacol 2019;10:11522019-10-11 00:00:002019-10-11 00:00:00Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles-A Novel Strategy for Enhancement of the Anti-tumor Immune Response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-09 / Front Immunol 2019;10:2353
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-09 / Front Immunol 2019;10:23532019-10-09 00:00:002020-11-30 10:24:49Dendritic Cell Vaccination in Metastatic Melanoma Turns „Non-T Cell Inflamed“ Into „T-Cell Inflamed“ Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-08 / Int. J. Cancer 2020 05;146(10):2822-2828
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-08 / Int. J. Cancer 2020 05;146(10):2822-28282019-10-08 00:00:002019-10-08 00:00:00A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeutics
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-05 / Nutrients 2019 Oct;11(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-05 / Nutrients 2019 Oct;11(10)2019-10-05 00:00:002019-10-05 00:00:00Curcumin and Cancer
